Page 5 - Margareta Horn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Margareta horn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Margareta Horn Today - Breaking & Trending Today

Q2 2023 EPS Estimates for Revolution Medicines, Inc. (NASDAQ:RVMD) Decreased by Analyst

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Rating) – SVB Leerink decreased their Q2 2023 earnings per share estimates for Revolution Medicines in a report released on Monday, May 8th. SVB Leerink analyst J. Chang now forecasts that the company will post earnings of ($0.85) per share for the quarter, down from their prior forecast of […] ....

Hong Kong , Thilo Schroeder , Margareta Horn , Great West Life Assurance Co , Securities Exchange Commission , Hong Kong Ltd , Allspring Global Investments Holdings , Jpmorgan Chase Co , Belpointe Asset Management , Revolution Medicines Inc , Needham Company , Simplex Trading , Revolution Medicines Company Profile , Goldman Sachs Group , Revolution Medicines , Get Rating , Revolution Medicine , Director Thilo Schroeder , Exchange Commission , Asset Management , Kong Ltd , West Life Assurance , Global Investments Holdings , Revolution Medicines Daily , Nasdaq Rvmd , Earnings Estimates ,

Revolution Medicines (NASDAQ:RVMD) Releases Quarterly Earnings Results, Beats Expectations By $0.12 EPS

Revolution Medicines (NASDAQ:RVMD – Get Rating) posted its earnings results on Monday. The company reported ($0.72) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.84) by $0.12, Briefing.com reports. Revolution Medicines had a negative net margin of 744.36% and a negative return on equity of 41.68%. The business had revenue of […] ....

Hong Kong , United States , Thilo Schroeder , Margareta Horn , Hong Kong Ltd , Revolution Medicines Inc , Goldman Sachs Group , Tower Research Capital , American Century Companies Inc , Ensign Peak Advisors Inc , Principal Financial Group Inc , Revolution Medicines Company Profile , Jpmorgan Chase Co , Needham Company , Revolution Medicines , Get Rating , Director Thilo Schroeder , Kong Ltd , Research Capital , Peak Advisors Inc , Century Companies , Principal Financial Group , Financial Group , Revolution Medicines Daily , Nasdaq Rvmd ,

Revolution Medicines (RVMD) Set to Announce Earnings on Monday

Revolution Medicines (NASDAQ:RVMD – Get Rating) is set to release its earnings data after the market closes on Monday, May 8th. Analysts expect Revolution Medicines to post earnings of ($0.84) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. Revolution Medicines (NASDAQ:RVMD […] ....

Thilo Schroeder , Margareta Horn , Vanguard Group Inc , Jpmorgan Chase Co , Blackrock Inc , Revolution Medicines Company Profile , Goldman Sachs Group , Revolution Medicines Inc , Needham Company , Norges Bank , Revolution Medicines , Get Rating , Director Thilo Schroeder , Street Corp , Revolution Medicines Daily , Nasdaq Rvmd ,

HC Wainwright Weighs in on Revolution Medicines, Inc.'s Q1 2023 Earnings (NASDAQ:RVMD)

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Rating) – HC Wainwright raised their Q1 2023 earnings estimates for Revolution Medicines in a report released on Wednesday, April 12th. HC Wainwright analyst R. Burns now expects that the company will earn ($0.78) per share for the quarter, up from their previous estimate of ($0.92). HC Wainwright currently […] ....

Thilo Schroeder , Margareta Horn , Jpmorgan Chase Co , Goldman Sachs Group , Blackrock Inc , Vanguard Group Inc , Needham Company , Bellevue Group , Revolution Medicines Inc , Revolution Medicines , Get Rating , Revolution Medicine , Director Thilo Schroeder , State Street Corp , Street Corp , Revolution Medicines Daily , Nasdaq Rvmd , Earnings Estimates , Hc Wainwright ,

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $32.25 Average Target Price from Analysts

Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Rating) have earned a consensus rating of “Moderate Buy” from the eight analysts that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1-year price target […] ....

United States , Margareta Horn , Thilo Schroeder , Jpmorgan Chase Co , Voya Investment Management , Securities Exchange Commission , Group Plc , Needham Company , Goldman Sachs Group , Squarepoint Ops , Revolution Medicines Company Profile , Revolution Medicines Inc , Revolution Medicines , Get Rating , Director Thilo Schroeder , Exchange Commission , Investment Management , Wisconsin Investment Board , General Group Plc , Revolution Medicines Daily , Nasdaq Rvmd ,